Showing results (231-240 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|August 31, 2021
Pharmacokinetics, Safety, and Tolerability of the α2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male SubjectsStefanie Kapsa, Uwe Thuss, Stefanie Boxnick, et al.
Clinical Pharmacology in Drug Development|February 14, 2023
Evaluation of Pharmacokinetics and Safety With Bioequivalence of Voriconazole Injection of 2 Formulations in Chinese Healthy Volunteers: Bioequivalence StudyChunqi Huang, Danqing Dong, Fei Yu, et al.
Clinical Pharmacology in Drug Development|March 21, 2023
Single- and Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1128, a Novel Peroxisome Proliferator-activated Receptor δ Modulator, in Healthy ParticipantsYuta Taniuchi, J W Olivier van Till, Tomasz Wojtkowski, et al.
Clinical Pharmacology in Drug Development|November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid TumorsXiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
Clinical Pharmacology in Drug Development|February 15, 2023
Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers: Effect of Food on AbsorptionWei Zhang, Lili Lin, Wanjin Fu, et al.
Clinical Pharmacology in Drug Development|November 28, 2025
Pharmacokinetics and Bioequivalence of Ilaprazole Enteric-Coated Tablets in Healthy Chinese Volunteers: A Two-Sequence, Four-Period, Fully Replicated Crossover StudyLijie Du, Yi Zhang, Fangliang Gan, et al.
Clinical Pharmacology in Drug Development|November 18, 2025
A pharmacokinetics study to evaluate drug-drug interactions between fipaxalparant and concomitant medications in healthy participantsYang Song, Krischan Hudson, Zhan Ye, et al.
Clinical Pharmacology in Drug Development|November 22, 2025
A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian IndividualsRajinder Bhardwaj, Chay Ngee Lim, Yinhua Li, et al.
Clinical Pharmacology in Drug Development|January 16, 2026
A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single-Dose Administration via Two Subcutaneous Injection Devices in Healthy VolunteersAngela Jeong, Kathleen Weisel, Dessislava Dimitrova, et al.
Clinical Pharmacology in Drug Development|August 22, 2025
Exposure-Response Analysis for Aripiprazole Once-Monthly in Patients Diagnosed With Bipolar I DisorderXiaofeng Wang, Luann Phillips, Matthew Harlin, et al.
Pageof 135